[68Ga]Ga-DOTA-DP-UBI 29-41: A Novel 68Ga-Labeled Ubiquicidin 29-41 Derivative Containing d-Proline for Bacterial Infection PET Imaging

IF 4.9 2区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL
Molecular Pharmaceutics Pub Date : 2026-08-03 Epub Date: 2026-07-02 DOI:10.1021/acs.molpharmaceut.6c00462
Yuhao Jiang, Peiwen Han, Yu Qian, Liyin Zhang, Yifu Sun, Guangxing Yin, Dajie Ding, Lina Diao, Ziqing Zhao, Jianyong Jiang, Junbo Zhang
{"title":"[68Ga]Ga-DOTA-DP-UBI 29-41: A Novel 68Ga-Labeled Ubiquicidin 29-41 Derivative Containing d-Proline for Bacterial Infection PET Imaging","authors":"Yuhao Jiang,&nbsp;Peiwen Han,&nbsp;Yu Qian,&nbsp;Liyin Zhang,&nbsp;Yifu Sun,&nbsp;Guangxing Yin,&nbsp;Dajie Ding,&nbsp;Lina Diao,&nbsp;Ziqing Zhao,&nbsp;Jianyong Jiang,&nbsp;Junbo Zhang","doi":"10.1021/acs.molpharmaceut.6c00462","DOIUrl":null,"url":null,"abstract":"<p>Bacterial infection poses a persistent\r\nand severe threat to human\r\nhealth. Accurate differentiation between bacterial infection and sterile\r\ninflammation is critical for timely clinical treatment. In this study,\r\na novel <sup>68</sup>Ga-labeled radiotracer ([<sup>68</sup>Ga]Ga-DOTA-DP-UBI\r\n29-41) was radiosynthesized by labeling the UBI 29-41 derivative (DOTA-DP-UBI\r\n29-41) with <sup>68</sup>Ga. This radiotracer was designed by introducing <span>d</span>-proline (DP) as a linker between the ubiquicidin 29-41 (UBI\r\n29-41) targeting segment and the 1,4,7,10-tetraazacyclododecane-<em>N</em>,<em>N</em>′,<em>N</em>,<em>N</em>′-tetraacetic acid (DOTA) chelating group. The radiotracer\r\nexhibited high radiochemical purity (RCP &gt; 98%) and favorable <em>in vitro</em> stability in normal saline at room temperature\r\nand mouse serum at 37 °C, with hydrophilic properties (Log<em>D</em> = −3.58 ± 0.04). <em>In vitro</em> bacterial experiments confirmed the specific and rapid binding of\r\nthis radiotracer to <em>Staphylococcus aureus</em>, with binding reaching equilibrium within 30 min of incubation and\r\nexhibiting concentration-dependent competitive inhibition with UBI\r\n29-41. Biodistribution studies in mouse models revealed effective\r\naccumulation of the tracer at bacterial infection sites (1.98 ±\r\n0.66% ID/g at 30 min p.i.), significantly lower renal uptake (stabilized\r\nat ∼25% ID/g) than previous <sup>68</sup>Ga-labeled UBI 29-41\r\nderivatives, and a distinct difference in uptake between bacterium-infected\r\nand sterile inflamed muscles (an infection-to-inflammation ratio of\r\n2.11 at 120 min p.i.). PET/CT imaging further confirmed that the tracer\r\ncould clearly visualize bacterial infection foci and distinguish infection\r\nfrom sterile inflammation in dual-pathology mice, with rapid blood\r\nclearance kinetics, renal metabolism, and excretion. Collectively,\r\nthese results indicate that [<sup>68</sup>Ga]Ga-DOTA-DP-UBI 29-41\r\nwill be a promising PET tracer for the specific diagnosis of bacterial\r\ninfection and differentiation from sterile inflammation.</p>","PeriodicalId":52,"journal":{"name":"Molecular Pharmaceutics","volume":"23 8","pages":"4263–4272"},"PeriodicalIF":4.9000,"publicationDate":"2026-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.6c00462","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/2 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Bacterial infection poses a persistent and severe threat to human health. Accurate differentiation between bacterial infection and sterile inflammation is critical for timely clinical treatment. In this study, a novel 68Ga-labeled radiotracer ([68Ga]Ga-DOTA-DP-UBI 29-41) was radiosynthesized by labeling the UBI 29-41 derivative (DOTA-DP-UBI 29-41) with 68Ga. This radiotracer was designed by introducing d-proline (DP) as a linker between the ubiquicidin 29-41 (UBI 29-41) targeting segment and the 1,4,7,10-tetraazacyclododecane-N,N′,N,N′-tetraacetic acid (DOTA) chelating group. The radiotracer exhibited high radiochemical purity (RCP > 98%) and favorable in vitro stability in normal saline at room temperature and mouse serum at 37 °C, with hydrophilic properties (LogD = −3.58 ± 0.04). In vitro bacterial experiments confirmed the specific and rapid binding of this radiotracer to Staphylococcus aureus, with binding reaching equilibrium within 30 min of incubation and exhibiting concentration-dependent competitive inhibition with UBI 29-41. Biodistribution studies in mouse models revealed effective accumulation of the tracer at bacterial infection sites (1.98 ± 0.66% ID/g at 30 min p.i.), significantly lower renal uptake (stabilized at ∼25% ID/g) than previous 68Ga-labeled UBI 29-41 derivatives, and a distinct difference in uptake between bacterium-infected and sterile inflamed muscles (an infection-to-inflammation ratio of 2.11 at 120 min p.i.). PET/CT imaging further confirmed that the tracer could clearly visualize bacterial infection foci and distinguish infection from sterile inflammation in dual-pathology mice, with rapid blood clearance kinetics, renal metabolism, and excretion. Collectively, these results indicate that [68Ga]Ga-DOTA-DP-UBI 29-41 will be a promising PET tracer for the specific diagnosis of bacterial infection and differentiation from sterile inflammation.

[68Ga]Ga-DOTA-DP-UBI 29-41:含d-脯氨酸的68Ga标记泛素29-41衍生物在细菌感染PET显像中的应用。
细菌感染对人类健康构成持续和严重的威胁。准确鉴别细菌性感染与无菌性炎症对临床及时治疗至关重要。本研究通过用68Ga标记UBI 29-41衍生物(DOTA-DP-UBI 29-41),合成了一种新型的68Ga标记放射性示踪剂([68Ga]Ga-DOTA-DP-UBI 29-41)。该放射性示踪剂通过引入d-脯氨酸(DP)作为泛素29-41 (UBI 29-41)靶向段与1,4,7,10-四氮杂环十二烷-N,N‘,N,N’-四乙酸(DOTA)螯合基团之间的连接物而设计。该放射性示踪剂具有较高的放射化学纯度(RCP > 98%),在室温生理盐水和37℃小鼠血清中具有良好的体外稳定性,亲水性(LogD = -3.58±0.04)。体外细菌实验证实了该示踪剂与金黄色葡萄球菌的特异性和快速结合,在孵育30分钟内达到平衡,并对UBI 29-41表现出浓度依赖性的竞争性抑制。小鼠模型的生物分布研究显示示踪剂在细菌感染部位的有效积累(30min每分钟1.98±0.66% ID/g),与之前的68ga标记的UBI 29-41衍生物相比,肾脏摄取显著降低(稳定在约25% ID/g),并且细菌感染和无菌炎症肌肉之间的摄取有明显差异(感染/炎症比为2.11在120min每分钟)。PET/CT成像进一步证实,该示踪剂可以清晰地显示双病理小鼠的细菌感染病灶,区分感染与无菌炎症,具有快速的血液清除动力学,肾脏代谢和排泄。综上所述,这些结果表明[68Ga]Ga-DOTA-DP-UBI 29-41将是一种有前景的PET示踪剂,用于细菌感染的特异性诊断和无菌炎症的鉴别。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Molecular Pharmaceutics
Molecular Pharmaceutics 医学-药学
CiteScore
8.00
自引率
6.10%
发文量
391
审稿时长
2 months
期刊介绍: Molecular Pharmaceutics publishes the results of original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. The journal encourages contributions describing research at the interface of drug discovery and drug development. Scientific areas within the scope of the journal include physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science as they relate to drug and drug delivery system efficacy. Mechanistic Drug Delivery and Drug Targeting research on modulating activity and efficacy of a drug or drug product is within the scope of Molecular Pharmaceutics. Theoretical and experimental peer-reviewed research articles, communications, reviews, and perspectives are welcomed.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书